Janux Therapeutics, Inc. (JANX)

Last Three Months

27-Aug-24 -- 26-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

17

0

0

+1

0

+2

0

+3

Two Year Chart

27-Nov-22 -- 26-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Sep-24 7:32 PM View:	27-Sep-24 Option Sale ($2.30M)	Meyer Andrew Hollman Chief Business Officer		Janux Therapeutics, Inc. - JANX	0% 67.59K	0	0	--	--	Show Txns Hide Txns

12-Sep-24 8:42 PM View:	12-Sep-24 Sale ($9.02M)	Avalon Ventures Xi, L.P. 10% Owner		Janux Therapeutics, Inc. - JANX	(4%) 10.23M to 9.78M	0	0	--	--	Show Txns Hide Txns

27-Sep-24 7:31 PM View:	27-Sep-24 Private Sale (Planned) ($231.72K)	Diraimondo Thomas Chief Scientific Officer		Janux Therapeutics, Inc. - JANX	(5%) 102.94K to 97.94K	0	0	--	--	Show Txns Hide Txns

27-Sep-24 7:30 PM View:	27-Sep-24 Private Sale (Planned) ($1.16M)	Campbell David Alan President and CEO Director		Janux Therapeutics, Inc. - JANX	(8%) 332.05K to 307.05K	0	0	--	--	Show Txns Hide Txns